Overlap of dyspepsia and gastroesophageal reflux in the general population: One disease or distinct entities?

Neurogastroenterology and Motility

Volumn 24, Issue 3, 2012, Pages

  Choung, R S ^a,b   Locke, G R ^a   Schleck, C D ^a   Zinsmeister, A R ^a   Talley, N J ^a,c  

^a MAYO CLINIC   (United States)

^b Korea University College of Medicine   (South Korea)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Dyspepsia; Gastroesophageal reflux; Population based study

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACKACHE; CHECKLIST; COHORT ANALYSIS; DISEASE ASSOCIATION; DIZZINESS; DYSPEPSIA; DYSPEPSIA GASTROESOPHAGEAL REFLUX OVERLAP; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEALTH SURVEY; HEARTBURN; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MUSCLE STIFFNESS; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; WEAKNESS;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MINNESOTA; QUESTIONNAIRES; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84856767906     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01845.x     Document Type: Article

References (40)

1. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-79.
2. Talley NJ, Stanghellini V, Heading RC et al. Functional gastroduodenal disorders. Gut 1999; 45(Suppl 2): II37-42.
3. Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009; 30: 331-42.
4. Locke GR 3rd, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
5. Talley NJ, Locke GR 3rd, Lahr BD et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006; 55: 933-9.
6. Ronkainen J, Aro P, Storskrubb T et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population - the Kalixanda study. Aliment Pharmacol Ther 2006; 23: 1725-33.
7. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 48-54.
8. Sarnelli G, De Giorgi F, Efficie E et al. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease. Eur J Gastroenterol Hepatol 2008; 20: 264-8.
9. Tack J, Caenepeel P, Arts J et al. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005; 54: 1370-6.
10. Talley NJ, Meineche-Schmidt V, Pare P et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 1055-65.
11. Guillemot F, Ducrotte P, Bueno L. Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice. Gastroenterol Clin Biol 2005; 29: 243-6.
12. Neumann H, Monkemuller K, Kandulski A et al. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig Dis 2008; 26: 243-7.
13. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74.
14. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981; 245: 54-63.
15. Talley NJ, Zinsmeister AR, Schleck CD et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
16. Talley NJ, Zinsmeister AR, Van Dyke C et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-34.
17. Talley NJ, Phillips SF, Melton J 3rd et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
18. Rey E, Locke GR 3rd, Jung HK et al. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Ther 2010; 31: 1237-47.
19. Talley NJ, Phillips SF, Wiltgen CM et al. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
20. Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
21. Attanasio V, Andrasik F, Blanchard EB et al. Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med 1984; 7: 247-57.
22. Choung RS, Locke GR 3rd, Zinsmeister AR et al. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol 2009; 104: 1772-9.
23. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
24. Jung HK, Halder S, McNally M et al. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther 2007; 26: 453-61.
25. Nastaskin I, Mehdikhani E, Conklin J et al. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci 2006; 51: 2113-20.
26. Kennedy TM, Jones RH, Hungin AP et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998; 43: 770-4.
27. Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) - is it one disease or an overlap of two disorders? Dig Dis Sci 2009; 54: 1829-34.
28. Talley NJ, Dennis EH, Schettler-Duncan VA et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003; 98: 2454-9.
29. Hillila MT, Siivola MT, Farkkila MA. Comorbidity and use of health-care services among irritable bowel syndrome sufferers. Scand J Gastroenterol 2007; 42: 799-806.
30. Piessevaux H, De Winter B, Louis E et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 2009; 21: 378-88.
31. Tack J. Is there a unifying role for visceral hypersensitivity and irritable bowel syndrome in non-erosive reflux disease? Digestion 2008; 78(Suppl 1): 42-5.
32. Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut 2008; 57: 674-83.
33. Kaji M, Fujiwara Y, Shiba M et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 2010; 25: 1151-6.
34. Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 1995; 90: 1797-803.
35. Choung RS, Locke GR, Schleck CD et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007; 102: 1983-9.
36. Gerson LB, Fass R. A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7: 372-8.
37. Schey R, Dickman R, Parthasarathy S et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 2007; 133: 1787-95.
38. Johnston BT, Gunning J, Lewis SA. Health care seeking by heartburn sufferers is associated with psychosocial factors. Am J Gastroenterol 1996; 91: 2500-4.
39. Koloski NA, Talley NJ, Huskic SS et al. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003; 17: 841-51.
40. Locke GR 3rd, Zinsmeister AR, Fett SL et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005; 17: 29-34.